SightfileU.S. market data from official filings

Procept Biorobotics Corp (PRCT)

Name: Procept Biorobotics Corp (PRCT) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001588978 · EDGAR filings · Updated 2026-06-10

Procept Biorobotics Corp (PRCT) has reported institutional ownership of 98.0%, with 255 institutional managers holding positions valued at $1.40B per the latest 13F reporting period.

Institutional ownership

98.0%

Institutional managers

255

Reported 13F value

$1.40B

Insider activity

59 trans.

$31.2K net buying

Latest updates

2026-06-10 — Insider transaction reported (Form 4)
2026-06-10 — Insider transaction reported (Form 4)
2026-06-10 — Insider transaction reported (Form 4)
2026-06-10 — Insider transaction reported (Form 4)
2026-06-10 — Insider transaction reported (Form 4)
2026-06-10 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Procept Biorobotics Corp has 255 institutional holders and institutional ownership of 98.0%.

Insider activity

Insiders reported 59 transactions (8 buys, 32 sells) across 13 reporting insiders, with a net reported value of $31.2K.

Related companies

MONTE ROSA THERAPEUTICS INC (GLUE) · BELITE BIO INC (BLTE) · INTELLIA THERAPEUTICS INC (NTLA) · BICARA THERAPEUTICS INC (BCAX) · KALVISTA PHARMACEUTICALS INC (KALV) · PROGYNY INC (PGNY)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-10.